These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28381307)

  • 1. Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.
    Maxwell AE; MacLeod MJ; Joyson A; Johnson S; Ramadan H; Bellfield R; Byrne A; McGhee C; Rudd A; Price F; Vasileiadis E; Holden M; Hewitt J; Carpenter M; Needle A; Valentine S; Patel F; Harrington F; Mudd P; Emsley H; Gregary B; Kane I; Muir K; Tiwari D; Owusu-Agyei P; Temple N; Sekaran L; Ragab S; England T; Hedstrom A; Jones P; Jones S; Doherty M; McCarron MO; Cohen DL; Tysoe S; Al-Shahi Salman R
    Trials; 2017 Apr; 18(1):162. PubMed ID: 28381307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).
    Maxwell AE; Dennis M; Rudd A; Weir CJ; Parker RA; Al-Shahi Salman R
    Trials; 2017 Mar; 18(1):22. PubMed ID: 28245843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
    Al-Shahi Salman R; Dennis MS; Murray GD; Innes K; Drever J; Dinsmore L; Williams C; White PM; Whiteley WN; Sandercock PAG; Sudlow CLM; Newby DE; Sprigg N; Werring DJ;
    Trials; 2018 Mar; 19(1):162. PubMed ID: 29506580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting Recruitment using Information Management Efficiently (PRIME): statistical analysis plan for a stepped wedge cluster randomised trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).
    Parker RA; Weir CJ; Maxwell AE; Al-Shahi Salman R
    Trials; 2017 Mar; 18(1):94. PubMed ID: 28253897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial.
    Al-Shahi Salman R; Murray GD; Dennis MS; Newby DE; Sandercock PAG; Sprigg N; Sudlow CLM; Werring DJ; White PM; Whiteley WN
    Trials; 2019 Mar; 20(1):183. PubMed ID: 30909946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    RESTART Collaboration
    Lancet; 2019 Jun; 393(10191):2613-2623. PubMed ID: 31128924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM;
    Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
    Al-Shahi Salman R; Dennis MS; Sandercock PAG; Sudlow CLM; Wardlaw JM; Whiteley WN; Murray GD; Stephen J; Rodriguez A; Lewis S; Werring DJ; White PM;
    JAMA Neurol; 2021 Oct; 78(10):1179-1186. PubMed ID: 34477823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
    Desborough MJR; Al-Shahi Salman R; Stanworth SJ; Havard D; Woodhouse LJ; Craig J; Krishnan K; Brennan PM; Dineen RA; Coats TJ; Hepburn T; Bath PM; Sprigg N;
    Lancet Neurol; 2023 Jul; 22(7):557-567. PubMed ID: 37353276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage.
    Al-Shahi Salman R; Greenberg SM
    Stroke; 2023 Dec; 54(12):3173-3181. PubMed ID: 37916459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting Recruitment using Information Management Efficiently (PRIME): a stepped-wedge, cluster randomised trial of a complex recruitment intervention embedded within the REstart or Stop Antithrombotics Randomised Trial.
    Maxwell AE; Parker RA; Drever J; Rudd A; Dennis MS; Weir CJ; Al-Shahi Salman R
    Trials; 2017 Dec; 18(1):623. PubMed ID: 29282142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial.
    Lewis R; Todd R; Newton M; Jones RJ; Wilson C; Donovan JL; Bryan RT; Birtle A; Hall E;
    Trials; 2020 Jul; 21(1):629. PubMed ID: 32641097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical analysis plan for the PlAtelet Transfusion in Cerebral Haemorrhage (PATCH) trial: a multicentre randomised controlled trial.
    Baharoglu MI; Al-Shahi Salman R; Cordonnier C; de Haan RJ; Roos YB
    Trials; 2016 Aug; 17():379. PubMed ID: 27484334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
    Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
    Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflecting on the methodological challenges of recruiting to a United Kingdom-wide, multi-centre, randomised controlled trial in gynaecology outpatient settings.
    Dickson S; Logan J; Hagen S; Stark D; Glazener C; McDonald AM; McPherson G
    Trials; 2013 Nov; 14():389. PubMed ID: 24228935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic drugs for carotid artery dissection.
    Lyrer P; Engelter S
    Cochrane Database Syst Rev; 2000; (4):CD000255. PubMed ID: 11034680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study).
    Shepherd V; Thomas-Jones E; Ridd MJ; Hood K; Addison K; Francis NA
    Trials; 2017 Nov; 18(1):533. PubMed ID: 29126461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds.
    Imaizumi T; Inamura S; Kohama I; Yoshifuji K; Nomura T; Komatsu K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):869-75. PubMed ID: 22959109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
    Aung T; Haynes R; Barton J; Cox J; Murawska A; Murphy K; Lay M; Armitage J; Bowman L;
    Trials; 2016 Jun; 17(1):286. PubMed ID: 27296091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.